...
tcbp-img

TC BioPharm Holdings PLC, Common Stock

TCBP

NAQ

$0.65

+$0.18

(38.38%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$360.37K
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
29.22M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.25
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.44 L
$41.5 H
$0.65

About TC BioPharm Holdings PLC, Common Stock

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTCBPSectorS&P500
1-Week Return16.39%-2.06%-0.55%
1-Month Return11.46%-1.92%2.72%
3-Month Return-89.76%-10.4%7.66%
6-Month Return-92.83%-4.6%10.15%
1-Year Return-97.39%4.06%27.53%
3-Year Return-100%1.94%32.31%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue3.43M1.98M1.98M3.84M-[{"date":"2019-12-31","value":89.14,"profit":true},{"date":"2020-12-31","value":51.47,"profit":true},{"date":"2021-12-31","value":51.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit3.43M1.98M1.98M3.84M-[{"date":"2019-12-31","value":89.14,"profit":true},{"date":"2020-12-31","value":51.47,"profit":true},{"date":"2021-12-31","value":51.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin100.00%100.00%100.00%100.00%-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses10.07M8.32M13.52M124.90K6.91M[{"date":"2019-12-31","value":74.44,"profit":true},{"date":"2020-12-31","value":61.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.92,"profit":true},{"date":"2023-12-31","value":51.12,"profit":true}]
Operating Income(6.62M)(6.89M)(7.29M)(12.08M)(14.24M)[{"date":"2019-12-31","value":-661863900,"profit":false},{"date":"2020-12-31","value":-688673900,"profit":false},{"date":"2021-12-31","value":-728702400,"profit":false},{"date":"2022-12-31","value":-1208399700,"profit":false},{"date":"2023-12-31","value":-1423932300,"profit":false}]
Total Non-Operating Income/Expense(528.92K)(582.07K)(11.13M)2.06M7.16M[{"date":"2019-12-31","value":-7.39,"profit":false},{"date":"2020-12-31","value":-8.13,"profit":false},{"date":"2021-12-31","value":-155.5,"profit":false},{"date":"2022-12-31","value":28.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(6.89M)(6.63M)(14.98M)(3.03M)(7.00M)[{"date":"2019-12-31","value":-689404900,"profit":false},{"date":"2020-12-31","value":-662984400,"profit":false},{"date":"2021-12-31","value":-1498346700,"profit":false},{"date":"2022-12-31","value":-303360100,"profit":false},{"date":"2023-12-31","value":-699568200,"profit":false}]
Income Taxes(826.07K)1.17M1.41M1.72M(1.09M)[{"date":"2019-12-31","value":-48.03,"profit":false},{"date":"2020-12-31","value":68.14,"profit":true},{"date":"2021-12-31","value":81.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-63.3,"profit":false}]
Income After Taxes(6.07M)(7.80M)(16.39M)(4.75M)(5.91M)[{"date":"2019-12-31","value":-606798400,"profit":false},{"date":"2020-12-31","value":-780177200,"profit":false},{"date":"2021-12-31","value":-1639100900,"profit":false},{"date":"2022-12-31","value":-475360100,"profit":false},{"date":"2023-12-31","value":-590695300,"profit":false}]
Income From Continuous Operations(6.07M)(5.46M)(13.58M)(1.39M)(5.91M)[{"date":"2019-12-31","value":-606798400,"profit":false},{"date":"2020-12-31","value":-545791600,"profit":false},{"date":"2021-12-31","value":-1357592500,"profit":false},{"date":"2022-12-31","value":-138970600,"profit":false},{"date":"2023-12-31","value":-590695300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(6.07M)(5.46M)(13.58M)(1.31M)(5.91M)[{"date":"2019-12-31","value":-606798400,"profit":false},{"date":"2020-12-31","value":-545791600,"profit":false},{"date":"2021-12-31","value":-1357592500,"profit":false},{"date":"2022-12-31","value":-131360100,"profit":false},{"date":"2023-12-31","value":-590695300,"profit":false}]
EPS (Diluted)--(9.37)--[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-936.69,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TCBP
Cash Ratio 0.28
Current Ratio 1.12

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TCBP
ROA (LTM) -108.92%
ROE (LTM) -1217.48%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TCBP
Debt Ratio Lower is generally better. Negative is bad. 0.71
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.29

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TCBP
Trailing PE NM
Forward PE NM
P/S (TTM) 0.51
P/B 1.51
Price/FCF NM
EV/R 1.83
EV/Ebitda NM

FAQs

What is TC BioPharm Holdings PLC share price today?

TC BioPharm Holdings PLC (TCBP) share price today is $0.65

Can Indians buy TC BioPharm Holdings PLC shares?

Yes, Indians can buy shares of TC BioPharm Holdings PLC (TCBP) on Vested. To buy TC BioPharm Holdings PLC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TCBP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of TC BioPharm Holdings PLC be purchased?

Yes, you can purchase fractional shares of TC BioPharm Holdings PLC (TCBP) via the Vested app. You can start investing in TC BioPharm Holdings PLC (TCBP) with a minimum investment of $1.

How to invest in TC BioPharm Holdings PLC shares from India?

You can invest in shares of TC BioPharm Holdings PLC (TCBP) via Vested in three simple steps:

  • Click on Sign Up or Invest in TCBP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in TC BioPharm Holdings PLC shares
What is TC BioPharm Holdings PLC 52-week high and low stock price?

The 52-week high price of TC BioPharm Holdings PLC (TCBP) is $41.5. The 52-week low price of TC BioPharm Holdings PLC (TCBP) is $0.44.

What is TC BioPharm Holdings PLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of TC BioPharm Holdings PLC (TCBP) is

What is TC BioPharm Holdings PLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of TC BioPharm Holdings PLC (TCBP) is 1.51

What is TC BioPharm Holdings PLC dividend yield?

The dividend yield of TC BioPharm Holdings PLC (TCBP) is 0.00%

What is the Market Cap of TC BioPharm Holdings PLC?

The market capitalization of TC BioPharm Holdings PLC (TCBP) is $360.37K

What is TC BioPharm Holdings PLC’s stock symbol?

The stock symbol (or ticker) of TC BioPharm Holdings PLC is TCBP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top